Tech Company Financing Transactions
Vir Biotechnology Funding Round
Vir Biotechnology, based in San Francisco, raised $500 million from Alaska Permanent Fund, Alta Partners and Altitude Life Science Ventures.
Transaction Overview
Company Name
Announced On
10/18/2017
Transaction Type
Venture Equity
Amount
$500,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Vir Biotechnology, Inc. today announced agreements with Humabs BioMed SA, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALYN), and Visterra, Inc., as well as four leading academic research institutions. Together with the company's internal research and development capabilities, these achievements provide the foundation on which Vir will pursue its mission of transforming the care of people with serious infectious diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
499 Illinois 500
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Undisclosed
Website
Email Address
Overview
Vir integrates diverse innovations in science, technology, and medicine to transform the care of people with serious infectious diseases. Vir is taking a multi-program, multi-platform approach to applying these breakthroughs, including the development of treatments that induce protective and therapeutic immune responses.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
George Scangos
Chief Financial Officer
Howard Horn
Chief Information Officer
Alex Bangs
Chief Operating Officer
Alpna Seth
Chief Scientific Officer
Herbert Virgin
Chief Technical Officer
Michael Kamarck
Vice President
Philip Pang
VP - Bus. Development
Jay Parrish
VP - Human Resources
Eric Schlezinger
VP - R & D
Antonio Lanzavecchia
Browse more venture capital transactions:
Prev: 10/18/2017: Covera venture capital transaction
Next: 10/18/2017: SelfMade venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs